Overton’s vaccine policy record raises legitimate doubts about her scientific judgment

Protection and improvement of community health through prevention, surveillance, education and policy rather than individual treatment. In the United States it is delivered mainly by state and local agencies, with federal bodies setting guidance that carries little binding force on them.

President Donald Trump’s nominee to lead the Food and Drug Administration, Dr. Heidi Overton, appeared before the Senate Health, Education, Labor and Pensions Committee for her confirmation hearing on September 24, 2026. Senators scrutinized her positions on mifepristone, vaccines, food safety, and agency independence.